The immunoevasive subtype of cervical cancer and the patient subpopulation of CD8+ T cells with high CD39 expression, due to enhanced CD39 enzymatic activity leading to excessive ADO production, drive immune evasion and poor prognosis. This evidence concerns the gene ENTPD1 and cervical carcinoma.